Zynerba Pharmaceuticals is developing novel transdermal cannabinoid therapies. Their lead candidate, ZYN002 (Zygel™), has shown success in mid-stage trials for Fragile X Syndrome, leading to positive community reactions and stock performance. The company focuses on delivering therapeutic cannabinoids through a topical gel for various conditions.
Visit Zynerba Pharmaceuticals Website ↗What is Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals is developing novel transdermal cannabinoid therapies. Their lead candidate, ZYN002 (Zygel™), has shown success in mid-stage trials for Fragile X Syndrome, leading to positive community reactions and stock performance. The company focuses on delivering therapeutic cannabinoids through a topical gel for various conditions. Based on 5 Reddit mentions across 3 subreddits, Zynerba Pharmaceuticals has a 20% positive sentiment score in the Pharma Tech space. Reddit users most frequently discuss Zynerba Pharmaceuticals in r/weedstocks.
Last scanned 22 days ago
Sentiment Breakdown
Top Subreddits
- r/weedstocks 3 mentions
- r/INCANNEX_IXHL_NASDAQ 1 mentions
- r/chicannabis 1 mentions
What Reddit Praises
- Successful clinical trial results
- Stock price increase
What Redditors Are Saying
"Zynerba's lead candidate ZYN002 successful in mid-stage Fragile X study; shares ahead 96% premarket"
"HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. - Zynerba"
"Zynerba Pharmaceuticals Reports Third Quarter 2017 Financial Results and Operational Highlights"
Other Pharma Tech Companies on Reddit
Track Zynerba Pharmaceuticals's Reddit presence in real-time
Get alerts when Zynerba Pharmaceuticals is mentioned on Reddit and respond before competitors do.
Start Free Trial